Prostate Cancer: Enough 'Me Too ’ Drugs

What we need are affordability endpoints, effective surrogate endpoints, and better information for our clinical colleagues, contend Drs. St é phane Oudard and Bertrand Tombal at ECC 2013.
Source: Medscape Urology Podcast - Category: Urology & Nephrology Authors: Source Type: podcasts